CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Repetitive Transcranial Magnetic Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05292547
NCT05292547N/ACompleted

Substance Misuse To Psychiatric Disorders-Repetitive Transcranial Magnetic Stimulation to People With Cannabis Use Disorder

The University of Hong Kong·interventional·Posted Mar 23, 2022·Updated Jul 8, 2025

In Brief

A clinical study evaluating Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder and Repetitive Transcranial Magnetic Stimulation. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This study is to explore if repetitive transcrinal magnetic stimulation (rTMS) with different stimulation schedules will be equally effective in reducing carving, frequency of cannabis use, and the severity of cannabis use disorder in participants suffering from cannabis use disorder (CUD). The investigators assume the hypotheses as: 1. Multiple rTMS sessions can reduce craving for cannabis, severity of CUD, frequency and amount of cannabis use. 2. Different rTMS treatment schedules have differences in reducing the craving for cannabis and severity of CUD, and prolonging relapse of cannabis use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesHong Kong
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 23, 2022
Enrollment StartSep 1, 2022
Primary CompletionMar 31, 2025
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 4.3 years ago

Interventions

Repetitive Transcranial Magnetic Stimulationdevice

rTMS using Magventure TMS system is delivered at the dorsolateral prefrontal cortex of consented subjects according to 3 different stimulation schedules.